[go: up one dir, main page]

PT71081A - 4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphtyridine derivatives - Google Patents

4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphtyridine derivatives

Info

Publication number
PT71081A
PT71081A PT71081A PT7108180A PT71081A PT 71081 A PT71081 A PT 71081A PT 71081 A PT71081 A PT 71081A PT 7108180 A PT7108180 A PT 7108180A PT 71081 A PT71081 A PT 71081A
Authority
PT
Portugal
Prior art keywords
dihydro
oxo
carboxy
cyano
amino
Prior art date
Application number
PT71081A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PT71081A publication Critical patent/PT71081A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT71081A 1979-04-18 1980-04-10 4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphtyridine derivatives PT71081A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3125579A 1979-04-18 1979-04-18
US06/125,600 US4324893A (en) 1979-04-18 1980-02-28 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives

Publications (1)

Publication Number Publication Date
PT71081A true PT71081A (en) 1980-05-01

Family

ID=26707004

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71081A PT71081A (en) 1979-04-18 1980-04-10 4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphtyridine derivatives

Country Status (22)

Country Link
US (1) US4324893A (pt)
EP (2) EP0018735B1 (pt)
JP (1) JPS56500373A (pt)
KR (1) KR840000076B1 (pt)
AR (2) AR225437A1 (pt)
AU (1) AU531348B2 (pt)
CA (1) CA1115272A (pt)
DK (1) DK537780A (pt)
ES (1) ES8104286A1 (pt)
FI (1) FI801229A (pt)
GB (1) GB2053198B (pt)
GR (1) GR67253B (pt)
HU (1) HU183125B (pt)
IE (1) IE49696B1 (pt)
IL (1) IL59667A (pt)
IN (1) IN150969B (pt)
NZ (1) NZ193445A (pt)
PH (1) PH16524A (pt)
PT (1) PT71081A (pt)
SU (1) SU1131469A3 (pt)
WO (1) WO1980002287A1 (pt)
YU (1) YU105680A (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420615A (en) * 1981-08-24 1983-12-13 Merck & Co., Inc. Substituted pyridopyrimidines as gastric secretion inhibitors
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
NZ218773A (en) * 1986-01-06 1990-05-28 Carpibem 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
FR2592649B1 (fr) * 1986-01-06 1988-04-29 Carpibem Cyano et amido phenyl-naphtyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
FR2592650B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines fonctionnalisees en position-3, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
NZ218774A (en) * 1986-01-06 1990-06-26 Carpibem 3-substituted phenylnaphthyridines and pharmaceutical compositions
FR2592651B1 (fr) * 1986-01-06 1988-05-13 Carpibem Nouvelles phenyl naphtyridines comportant un substituant methyle en position 3, et les medicaments qui en contiennent.
FR2592652B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines, leur procede de preparation et les medicaments en contenant.
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
FR2632861B1 (fr) * 1988-06-15 1990-11-09 Sanofi Sa Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments
FR2632639B1 (fr) * 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
FR2637890B1 (fr) * 1988-09-14 1991-02-01 Europ Propulsion Materiau composite a matrice zircone
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
TWI262919B (en) 1999-10-25 2006-10-01 Yamanouchi Pharma Co Ltd Naphthyridine derivative
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
KR20020092756A (ko) * 2001-06-05 2002-12-12 이종완 젓갈과 그 제조 방법
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2004091627A2 (en) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
BRPI0413695A (pt) 2003-08-22 2006-10-24 Avanir Pharmaceuticals derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
US20060229314A1 (en) 2005-03-24 2006-10-12 Jagadish Sircar Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
KR102650565B1 (ko) 2017-09-28 2024-03-26 트랜스테라 사이언시즈 (난징), 인크. Pde9 억제제 및 이의 용도
CA3104654A1 (en) 2018-06-27 2020-01-02 Bristol-Myers Squibb Company Substituted naphthyridinone compounds useful as t cell activators
AU2019291792B2 (en) 2018-06-27 2022-09-29 Bristol-Myers Squibb Company Naphthyridinone compounds useful as T cell activators
AR119821A1 (es) 2019-08-28 2022-01-12 Bristol Myers Squibb Co Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
AR120823A1 (es) 2019-12-23 2022-03-23 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como activadores de células t

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103805C3 (de) * 1970-01-28 1980-03-20 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen
CA988522A (en) * 1972-05-05 1976-05-04 Haydn W.R. Williams 1,8-naphthyridine compounds
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4103257A (en) * 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
US4133885A (en) * 1977-07-18 1979-01-09 Merck & Co., Inc. Substituted naphthyridinones

Also Published As

Publication number Publication date
EP0018735A1 (en) 1980-11-12
CA1115272A (en) 1981-12-29
IN150969B (pt) 1983-02-05
HU183125B (en) 1984-04-28
WO1980002287A1 (en) 1980-10-30
EP0060012B1 (en) 1984-08-29
GR67253B (pt) 1981-06-26
US4324893A (en) 1982-04-13
ES490645A0 (es) 1981-04-16
YU105680A (en) 1983-09-30
NZ193445A (en) 1982-09-07
PH16524A (en) 1983-11-10
GB2053198B (en) 1983-04-07
IE800761L (en) 1980-10-18
AU531348B2 (en) 1983-08-18
JPS56500373A (pt) 1981-03-26
DK537780A (da) 1980-12-17
KR840000076B1 (ko) 1984-02-08
AU5751980A (en) 1980-10-23
GB2053198A (en) 1981-02-04
SU1131469A3 (ru) 1984-12-23
AR225437A1 (es) 1982-03-31
IL59667A (en) 1983-11-30
FI801229A (fi) 1980-10-19
AR227427A1 (es) 1982-10-29
KR830002759A (ko) 1983-05-30
EP0018735B1 (en) 1983-07-27
IE49696B1 (en) 1985-11-27
ES8104286A1 (es) 1981-04-16
EP0060012A1 (en) 1982-09-15

Similar Documents

Publication Publication Date Title
PT71081A (en) 4-amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphtyridine derivatives
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
GB2043639B (en) 3-optionally substituted methyl-2-penem derivatives
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
ZA807494B (en) 2,3-indoledione derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
CU35300A (en) Pyrrholidine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
GB2042549B (en) 25 - hydroxy-cholecalciferol - 26,23 - lactone
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
NZ192622A (en) 4,7-phenanthroline derivatives
GB2040932B (en) 1 - substituted - 3,4 - epoxypyrrolidines
GB2065110B (en) Decaprenylamine derivatives
GB2042519B (en) 1,1,2-triphenylethane and -ehylene derivatives